These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36413430)

  • 1. Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department.
    Ghosh P; Martinez J; Shah N; Kenan W; Fowler A; Limdi N; Burns L; Cogan ES; Gardiner A; Hain D; Johnson H; Lewis D; Shelton R; Liebelt E
    Pediatr Emerg Care; 2023 Jan; 39(1):6-12. PubMed ID: 36413430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
    Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF
    Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
    Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder.
    Shelton RC; Parikh SV; Law RA; Rothschild AJ; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Macaluso M; Hain DT; Aguilar AL; Brown K; Lewis DJ; Jablonski MR; Greden JF
    Psychiatry Res; 2020 Aug; 290():113017. PubMed ID: 32485484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Outcomes Following Combinatorial Pharmacogenomic Testing for Elderly Psychiatric Patients.
    Jablonski MR; Lorenz R; Li J; Dechairo BM
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):324-332. PubMed ID: 31842673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world experience of using combinatorial pharmacogenomic test in children and adolescents with depression and anxiety.
    Dagar A; Cherlopalle S; Ahuja V; Senko L; Butler RS; Austerman J; Anand A; Falcone T
    J Psychiatr Res; 2022 Feb; 146():83-86. PubMed ID: 34959162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Events in Very Young Children Prescribed Psychotropic Medications: Preliminary Findings from an Acute Clinical Sample.
    Lee CS; Williamson LR; Martin SE; DeMarco M; Majczak M; Martini J; Hunter HL; Fritz G; Boekamp J
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):509-13. PubMed ID: 26262905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial.
    Thase ME; Parikh SV; Rothschild AJ; Dunlop BW; DeBattista C; Conway CR; Forester BP; Mondimore FM; Shelton RC; Macaluso M; Li J; Brown K; Jablonski MR; Greden JF
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31721487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.
    Brown LC; Lorenz RA; Li J; Dechairo BM
    Clin Ther; 2017 Mar; 39(3):592-602.e1. PubMed ID: 28238356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications.
    Tanner JA; Brown LC; Yu K; Li J; Dechairo BM
    Clinicoecon Outcomes Res; 2019; 11():779-787. PubMed ID: 31849503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data.
    Bobo WV; Angleró GC; Jenkins G; Hall-Flavin DK; Weinshilboum R; Biernacka JM
    Hum Psychopharmacol; 2016 May; 31(3):185-92. PubMed ID: 26999588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists.
    Tanner JA; Davies PE; Voudouris NC; Shahmirian A; Herbert D; Braganza N; Gugila A; Dechairo BM; Kennedy JL
    J Psychiatr Res; 2018 Sep; 104():157-162. PubMed ID: 30081389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications.
    Hull LE; Chanfreau-Coffinier C; Tuteja S; Berlowitz D; Lehmann LS; Oslin DW; Pyne JM; DuVall SL; Lynch JA
    Pharmacogenomics; 2019 Jul; 20(11):781-789. PubMed ID: 31393222
    [No Abstract]   [Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are psychotropic medications associated with differences in baseline neurocognitive assessment scores for young athletes? A pilot study.
    Yengo-Kahn AM; Solomon G
    Phys Sportsmed; 2015 Jul; 43(3):227-35. PubMed ID: 26200262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic medication use for paediatric mental health patients in an emergency department.
    O'Donnell SM; Carison A; Hill A; Say D; Hiscock H; Babl FE
    Emerg Med Australas; 2021 Apr; 33(2):292-301. PubMed ID: 33000554
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.